The U.S. Centers for Disease Control and Prevention (CDC) this week said that reports of a nervous system disorder known as Guillain-Barre syndrome are “more common than expected” in older adults who got new RSV vaccines.
On Thursday, the agency said that the elevated reports of Guillain-Barre syndrome, of GBS, “are consistent with those from trials,” and it echoes a similar report published by the CDC earlier this year.
